Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Immunogenetics of Melanoma Publisher Pubmed



Darbeheshti F1, 2
Authors

Source: Advances in Experimental Medicine and Biology Published:2022


Abstract

Melanoma is a relatively common and deadly type of skin cancer that originates from melanocytes. Cutaneous malignant melanoma results from the interplay between genetic susceptibility and environmental factors. Though the majority of melanoma cases are sporadic, several high and low penetrance mutations have been identified as underlying factors of heritable melanoma. Genetic variations in immune system components are among the most studied factors in melanoma heritability. They are involved in several aspects of the pathogenesis of the tumor including predisposition, cell proliferation, and apoptosis as well as immunotherapy. In this chapter, the hitherto available immunogenetic-related reports on melanoma predisposition and progression are summed up. © 2022, Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. Immunopathology and Immunotherapy of Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2020)
2. Immune Therapy of Melanoma: Overview of Therapeutic Vaccines, Journal of Cellular Physiology (2019)
3. Patients’ Characteristics, Histopathological Findings, and Tumor Stage in Different Types of Malignant Melanoma: A Retrospective Multicenter Study, Acta Medica Iranica (2017)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (6)
Alireza Ghanadan (5)
Other Related Docs
4. Study on Early Onset Melanoma and Germ-Line Mutation in Cdkn2a Among Patients in Imam Khomeini Hospital Complex, Asian Pacific Journal of Cancer Prevention (2021)
5. Cancer Immunology, Encyclopedia of Infection and Immunity (2022)
6. Tumor Immunology, Clinical Immunology (2022)
7. Prevalence of Braf V600e and Nras (G12v, G13v) Mutations in Iranian Patients With Melanoma and Their Association With Tumor-Related Factors, Iranian Journal of Dermatology (2024)
8. Skin Cancer: Genetics, Immunology, Treatments, and Psychological Care, Cancer Genetics and Psychotherapy (2017)
9. Tumor Infiltrating Lymphocytes in Different Stages of Malignant Melanoma and Correlation With Tumor Stage and Other Prognostic Factors: A Retrospective Multicenter Study, Middle East Journal of Cancer (2017)
10. Immune Checkpoint Blockade in Melanoma: Advantages, Shortcomings and Emerging Roles of the Nanoparticles, International Immunopharmacology (2022)
11. Cell Cycle Regulatory Markers in Melanoma: New Strategies in Diagnosis and Treatment, Medical Journal of the Islamic Republic of Iran (2019)
12. Immunology of Cutaneous Tumors and Immunotherapy for Melanoma, Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors (2015)
13. Tumor Immunotherapies by Immune Checkpoint Inhibitors (Icis); the Pros and Cons, Cell Communication and Signaling (2022)
14. A Comparative Study of Long Interspersed Element-1 Protein Immunoreactivity in Cutaneous Malignancies, BMC Cancer (2020)
15. The Potential of Circulating Mir-193B, Mir-146B-3P and Mir-483-3P As Noninvasive Biomarkers in Cutaneous Melanoma Patients, Molecular Biotechnology (2023)
16. Pd-1/Pd-L1 Pathway: Basic Biology and Role in Cancer Immunotherapy, Journal of Cellular Physiology (2019)
17. Differential Bmi1, Twist1, Snai2 Mrna Expression Pattern Correlation With Malignancy Type in a Spectrum of Common Cutaneous Malignancies: Basal Cell Carcinoma, Squamous Cell Carcinoma, and Melanoma, Clinical and Translational Oncology (2017)
18. Exosomal Long Non-Coding Rnas: Novel Molecules in Gastrointestinal Cancers’ Progression and Diagnosis, Frontiers in Oncology (2022)
19. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2019)
20. Immunotherapeutic Approaches in Cancer, Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives (2018)